| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 05/02/2001 | EP1095061A1 Peptides based on the sequence of human lactoferrin and their use |
| 05/02/2001 | EP1095058A1 Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same |
| 05/02/2001 | EP1095057A1 Matrix metalloproteinase inhibitors containing aminomalonic acid derivatives and peptide backbone modified derivatives thereof |
| 05/02/2001 | EP1094829A2 Methods for accelerating bone and cartilage growth and repair |
| 05/02/2001 | EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 05/02/2001 | CN1293201A Process for separating and extracting nisin from fermented liquid |
| 05/01/2001 | US6225625 Signal detection methods and apparatus |
| 05/01/2001 | US6225444 Bind calcium and which are useful in treating stroke and other neurodegenerative diseases |
| 05/01/2001 | CA2195395C Cyclic hexapeptide somatostatin analogues |
| 05/01/2001 | CA2081660C Method for improving the organoleptic qualities of the meat from uncastrated male domestic animals and vaccine set for use in this method |
| 05/01/2001 | CA1341222C Preparations of islet amyloid polypeptide (iapp) and antibodies to iapp |
| 04/26/2001 | WO2001029563A1 Method of screening for inhibitors of asp2 |
| 04/26/2001 | WO2001029213A1 Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof |
| 04/26/2001 | WO2001029081A1 Modified peptides and peptidomimetics for use in immunotherapy |
| 04/26/2001 | WO2001029065A1 Process for preparing peptide intermediates |
| 04/26/2001 | WO2001028595A1 Cobalamin conjugates useful as imaging and therapeutic agents |
| 04/26/2001 | WO2001028576A2 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY |
| 04/26/2001 | WO2000063246A3 Compounds and methods for modulating beta-catenin mediated gene expression |
| 04/26/2001 | CA2387995A1 Process for preparing peptide intermediates |
| 04/26/2001 | CA2387767A1 Cobalamin conjugates useful as imaging and therapeutic agents |
| 04/26/2001 | CA2387041A1 Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof |
| 04/26/2001 | CA2386398A1 Modified peptides and peptidomimetics for use in immunotherapy |
| 04/25/2001 | EP1094074A2 Radioactively-labeled somatostatin derived peptides for imaging and therapeutic uses |
| 04/25/2001 | EP1094072A1 Peptides having corticotropin releasing factor (CRF) antagonist activity |
| 04/25/2001 | EP1093804A1 Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin |
| 04/25/2001 | EP1093460A1 Dolastatin 15 derivatives |
| 04/25/2001 | EP1093458A1 Process for the preparation of resin-bound cyclic peptides |
| 04/24/2001 | US6222018 Antibody which binds to transcription factor; for detection in samples; for screening expression libraries |
| 04/24/2001 | US6222012 Isolated nonapeptides presented by HLA molecules, and uses thereof |
| 04/24/2001 | US6222011 Antigenic peptides |
| 04/24/2001 | US6221958 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 04/24/2001 | US6221846 Ophthalmic drug compositions |
| 04/24/2001 | US6221844 Texenomycins having a specific amino acid sequence |
| 04/24/2001 | US6221591 Determination of a genetic risk factor for infection and other diseases, and detection of activated phagocytes |
| 04/24/2001 | US6221577 Peptides which induce immune response and are useful in the diagnosis of urogenital tumors |
| 04/24/2001 | CA2111863C Technetium-99m labeled peptides for imaging |
| 04/24/2001 | CA2079172C Cyclohexapeptidyl hydroxypropionitrile compounds |
| 04/19/2001 | WO2001027628A1 Antibiotic-metal complexes in the detection of gram-negative bacteria and other biological analytes |
| 04/19/2001 | WO2001027261A2 Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino |
| 04/19/2001 | WO2001027139A1 Drug for treatment of immunodeficiency states |
| 04/19/2001 | WO2001027136A2 Peptides which stimulate the immune response and tissue regeneration |
| 04/19/2001 | WO2001026682A2 Modified plant viruses and methods of use thereof |
| 04/19/2001 | WO2001026673A1 Antibiotic-metal complex and methods |
| 04/19/2001 | WO2000077031A3 Muc1 ligands |
| 04/19/2001 | WO2000070665A3 Long lasting anti-angiogenic peptides |
| 04/19/2001 | CA2388991A1 Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino |
| 04/19/2001 | CA2387629A1 Modified plant viruses and methods of use thereof |
| 04/19/2001 | CA2387604A1 Peptides which stimulate the immune response and tissue regeneration |
| 04/18/2001 | EP1092770A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 04/18/2001 | EP1092724A2 Angiotensin converting enzyme inhibitor |
| 04/18/2001 | EP1091975A1 Novel cyclosporin with improved activity profile |
| 04/18/2001 | EP1091966A1 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ace) |
| 04/18/2001 | EP1091754A1 Crosslink-stabilized indolicidin analogs |
| 04/18/2001 | EP1091753A1 Antiproliferative and antiviral proteins and peptides |
| 04/18/2001 | EP0725790B1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase |
| 04/18/2001 | CN1291991A Novel peptide having biological activity |
| 04/17/2001 | US6218364 Fluorinated neurokinin A antagonists |
| 04/17/2001 | US6217893 Sustained-release compositions and method for preparing same |
| 04/17/2001 | US6217846 Synthetic peptides for use in thrombus detection |
| 04/17/2001 | CA2152267C Difluoro-pentapeptide derivative anti-inflammatory agents |
| 04/17/2001 | CA2064473C Chimeric amino acids and peptides containing these analogues |
| 04/12/2001 | WO2001025397A2 Compositions and methods for tumor-targeted delivery of effector molecules |
| 04/12/2001 | WO2001025275A1 Regulatory/unfolding peptides of ezrin |
| 04/12/2001 | WO2001025266A1 Uroguanylin as an intestinal cancer inhibiting agent |
| 04/12/2001 | WO2001025265A1 Metal-binding compounds and uses therefor |
| 04/12/2001 | WO2001025264A2 Substituted phosphinate based peptide derivatives |
| 04/12/2001 | WO2001025257A2 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 04/12/2001 | WO2001024810A1 Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions |
| 04/12/2001 | WO2001024789A1 Agents for reducing cholesterol-uptake and liquid-uptake |
| 04/12/2001 | WO2000071570A8 Solid phase peptide synthesis method |
| 04/12/2001 | CA2386499A1 Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions |
| 04/12/2001 | CA2386465A1 Compositions and methods for tumor-targeted delivery of effector molecules |
| 04/12/2001 | CA2385961A1 Agents for reducing cholesterol-uptake and liquid-uptake |
| 04/12/2001 | CA2385551A1 Metal-binding compounds and uses therefor |
| 04/12/2001 | CA2348780A1 Regulatory/unfolding peptides of ezrin |
| 04/11/2001 | EP1090994A2 Peptide repeat immunogens |
| 04/11/2001 | EP1090641A2 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides |
| 04/11/2001 | EP1090634A1 Agents for reducing cholesterol and lipid uptake |
| 04/11/2001 | EP1090140A1 Method for screening for substances which are activators or inhibitors of protein kinase b |
| 04/11/2001 | EP1089757A1 Hla binding peptides and their uses |
| 04/11/2001 | EP1089755A2 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 04/11/2001 | EP0750506B1 Broad spectrum antimicrobial compounds and methods of use |
| 04/11/2001 | CN1291231A Human telomerase catalytic subunit |
| 04/10/2001 | US6215044 Nucleotide and amino acid sequence; for transgenic plants with altered phenotypes especially during ripening |
| 04/10/2001 | US6214969 Luteinizing hormone releasing hormone analogs with cytotoxic moiety |
| 04/10/2001 | US6214798 Polypeptides |
| 04/10/2001 | US6214795 Polypetides with amino acid sequences |
| 04/10/2001 | US6214793 Method of treating tumors with thiodepsipeptide isolated from a marine actinomycete |
| 04/10/2001 | US6214790 Neo-tryptophan |
| 04/10/2001 | US6214584 Nucleotide sequence which encodes polypeptide associated with immunocompetence; for use in the treatment and prevent of tumors, viral diseases, bacterial infections and autoimmune diseases |
| 04/10/2001 | CA2140543C Thrombin receptor antagonists |
| 04/10/2001 | CA2074089C Extracellular segments of human e immunoglobulin anchoring peptides and antibodies specific therefor |
| 04/10/2001 | CA2067233C Fibronectin binding peptide |
| 04/05/2001 | WO2001023604A2 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| 04/05/2001 | WO2001023429A1 Immunointeractive molecules and their uses in treating subjects suffering from hev b 5 allergies |
| 04/05/2001 | WO2001022816A1 MODULATION OF ηδ T CELLS TO REGULATE AIRWAY HYPERRESPONSIVENESS |
| 04/05/2001 | WO2000071573A3 Immunogenic peptides derived from mage and the use thereof |
| 04/05/2001 | DE19948644A1 New peptaibol peptides produced by Sepedonium fungus, useful as antibacterial, antifungal, neuroleptic and anxiolytic agents |
| 04/05/2001 | CA2811455A1 Highly conserved genes and their use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes and amplification primers to rapidly detect and identify algal, archaeal, bacterial, fungal and parasitical microorganisms from clinical specimens for diagnosis |
| 04/05/2001 | CA2388461A1 Highly conserved genes and their use to generate probes and primers for the detection of microorganisms |